1. FDA. 21st Century Cures Act 2018. Available from: .
2. FDA. Guidance for industry: expedited programs for regenerative medicine therapies for serious conditions. Available from: ; 2019.
3. FDA. Evaluation of devices used with regenerative medicine advanced therapies. Available from: ; 2019.
4. FDA. Amendments to sterility test requirements for biological products. Available from: ; 2012.
5. FDA. Guidance for FDA reviewers and sponsors: content and review of chemistry, manufacturing, and control (CMC) information for human somatic cell therapy investigational new drug applications (INDs). Available from: ; 2008.